Fingolimod granted FDA Breakthrough Therapy designation for paediatric MS
Novartis today announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for fingolimod for the treatment of children and adolescents 10 years of age or older with relapsing multiple sclerosis (MS)...Read more - http://www.ms-uk.org/fingolimod-granted ... diatric-ms
Fingolimod granted FDA Breakthrough Therapy designation...
Fingolimod granted FDA Breakthrough Therapy designation...
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2149 Views
-
Last post by frodo
-
- 0 Replies
- 9858 Views
-
Last post by NHE
-
- 2 Replies
- 1632 Views
-
Last post by jimmylegs
-
- 0 Replies
- 1819 Views
-
Last post by Petr75
-
- 0 Replies
- 1208 Views
-
Last post by NHE
-
- 2 Replies
- 1857 Views
-
Last post by frodo
-
- 0 Replies
- 10711 Views
-
Last post by NHE
-
- 0 Replies
- 2486 Views
-
Last post by frodo
-
- 0 Replies
- 2607 Views
-
Last post by NHE